Open to Accrual

Studies that are open to accrual

A5360: Monitoring SOF-VEL in Treatment Naive, HCV Participants with Active Infection

A Single-arm Study to Evaluate the Feasibility and Efficacy of a Minimal Monitoring Strategy to Deliver Pan-genotypic Ribavirin-free HCV Therapy to HCV Infected Populations who are HCV Treatment Naïve with Evidence of Active HCV Infection: The MINMON Study

A5345: HIV Rebound & Control Biomarkers

Identification of Biomarkers to Predict Time to Plasma HIV RNA Rebound and Post-Treatment Viral Control during an Intensively Monitored Antiretroviral Pause (IMAP)

Treatment Category: 

Treatment Experienced

A5351s: Immune-modularity drugs and CMV replication

Effect of Immune-Modulatory Interventions on Cytomegalovirus Replication during Suppressive Antiretroviral Therapy

Study Description
Cytomegalovirus (CMV) is a relatively common kind of herpes virus that is usually harmless but is capable of producing severe problems for individuals with compromised immune systems, such as people who are HIV-1 infected.  Recent studies suggest that even when no symptoms are present, when CMV replicates (makes more copies of itself), it could contribute to the inflammation in the body.

Subscribe to RSS - Open to Accrual